TP53 and neoplasm: Table 1 shows a summary of statistics for 23 selected TCGA BRCA clinical variables, characterizing tumor gene expression, gene variation, somatic mutations, TP53 mutations, genome alterations, and a group of clinically significant scores correlated with KDM7A-DT’s log2 RNA levels from 1072 tumors of female patients.